Crimean-Congo hemorrhagic fever: Prevention and control limitations in a resource-poor country

Clinical Infectious Diseases

Volumn 38, Issue 12, 2004, Pages 1731-1735

  Smego Jr , Raymond A ^a   Sarwari, Arif R ^b   Siddiqui, Amna Rehana ^c  

^a UND School of Medicine & Health Sciences Southeast Campus   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; RIBAVIRIN; VIRUS ANTIGEN;

ARENAVIRUS; ARTICLE; BLOOD SAMPLING; BUNYAVIRUS; DEVELOPING COUNTRY; DISINFECTION; EBOLA VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; FEVER; FILOVIRUS; FLAVIVIRUS; HANTAVIRUS; HEALTH CARE PERSONNEL; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; NURSING; POLITICS; PRIORITY JOURNAL; SPLENOMEGALY; THROMBOCYTOPENIA; VIRUS HEMORRHAGIC FEVER; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; CONTACT TRACING; CROSS INFECTION; DEVELOPING COUNTRIES; DISEASE OUTBREAKS; HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; MIDDLE AGED; PAKISTAN;

EID: 2942674278     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/421093     Document Type: Article

References (11)

1. Lacy MA, Smego RA Jr. Viral hemorrhagic fevers. In: Aranoff SA, ed. Advances in pediatric infectious diseases. St. Louis: Mosby Year Book, 1997:21-53.
2. Weber DJ, Rutala WA. Risks and prevention of nosocomial transmission of rare zoonotic diseases [review]. Clin Infect Dis 2001; 32:446-56.
3. Management of patients with suspected viral hemorrhagic fever [review]. MMWR Morb Mortal Wkly Rep 1988; 37(Suppl 3):1-16.
4. Altaf A, Luby S, Ahmed AJ, et al. Outbreak of Crimean-Congo haemorrhagic fever in Quetta, Pakistan: contact tracing and risk assessment. Trop Med Int Health 1998; 3:878-82.
5. Burney MI, Ghafoor A, Saleem M, Webb PA, Casals J. Nosocomial outbreak of viral hemorrhagic fever caused by Crimean hemorrhagic fever - Congo virus in Pakistan, January 1976. Am J Trop Med Hyg 1980; 29:941-7.
6. Hoogstral H. The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa. J Med Entomol 1979; 15: 307-17.
7. Sagoe-Moses C, Pearson RD, Perry J, Jagger J. Risks to health care workers in developing countries. N Engl J Med 2001; 345:538-41.
8. Fine A, Layton M. Lessons from the West Nile viral encephalitis outbreak in New York City, 1999: implications for bioterrorism preparedness. Clin Infect Dis 2001; 32:277-82.
9. Fisher-Hoch SP, Khan AJ, Rehman S, Mirza S, Khurshid M, McCormick JB. Crimean-Congo haemorrhagic fever treated with oral ribavirin. Lancet 1995; 346:472-5.
10. McCormick JB, King IJ, Webb PA, et al. Lassa fever: effective therapy with ribavirin, a broad spectrum antiviral drug. N Engl J Med 1986; 314:20-6.
11. Huggins JW, Hsiang CM, Cosgriff TM, et al. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J Infect Dis 1991; 164:1119-27.